At a glance
ClinicalIndex Comparison RecordN/ACompleted· 63 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Chronic Neuropathy Following Chemotherapy
In Brief
An observational study for Peripheral Nervous System Diseases and Chronic Pain. Completed, enrolled 63 participants across 1 site.
Detailed Summary
This is a clinical study which is a follow-up of a previous prospective questionnaire study. All patients who previously participated in the study will receive a new questionnaire and will be invited for a clinical examination.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Nervous System Diseases, Chronic Pain
CountriesDenmark
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 2016
Enrollment StartJun 2016
Primary CompletionApr 2017
Study CompletionJul 2019
TodayJul 2026
First PostedJan 13, 2016
Enrollment StartJun 1, 2016
Primary CompletionApr 1, 2017
Study CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.5 years ago